Table 2 Baseline characteristics of AIH patients as stratified per treatment category. Median and interquartile ranges are shown unless indicated otherwise

Patients

14

31

21

Sex (F/M)

7/7

23/8

17/4

Age female

59 [51–64]

49 [28–64]

43 [26–57]

Age male

51 [37–66]

57 [30–62]

56 [38–67]

Cirrhosis

No cirrhosis

9

17

13

Compensated cirrhosis

4

11

7

Decompensated cirrhosis

1

3

1

Laboratory values

AST (IU/L)

169 [108–415]

60 [50–94]

26 [24–30]

ALT (IU/L)

189 [105–304]

63 [39–127]

19 [15–27]

ALP (IU/L)

161 [106–191]

112 [77–162]

62 [49–73]

GGT (IU/L)

236 [118–394]

119 [44–258]

34 [26–72]

IgG (g/L)

19 [13–22]

16 [13–18]

11 [8–11]

Medication

No medication

14

-

-

Steroid based treatment

-

27

16

Steroid free treatment

-

4

5